{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:54:53Z","timestamp":1783072493128,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ejogrb.2004.11.023","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:55:01Z","timestamp":1118404501000},"page":"8-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Risk of venous thromboembolic disease in women"],"prefix":"10.1016","volume":"121","author":[{"given":"Alberto","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Manuel","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel-Angel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2004.11.023_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1055\/s-0037-1616243","article-title":"The epidemiology of venous thromboembolism in the community","volume":"86","author":"Heit","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib3","doi-asserted-by":"crossref","first-page":"132S","DOI":"10.1378\/chest.119.1_suppl.132S","article-title":"Prevention of venous thromboembolism","volume":"119","author":"Geerts","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1067\/mob.2000.105441","article-title":"Risk factor scoring for predicting venous thromboembolism in obstetric patients","volume":"182","author":"Weiss","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0895-4356(91)90160-B","article-title":"Validation of an index of the quality of review articles","volume":"44","author":"Oxman","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.1994.00420080053005","article-title":"The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly","volume":"154","author":"Kniffin","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case- fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2796.1992.tb00565.x","article-title":"A prospective study of the incidence of deep-vein thrombosis within a defined urban population","volume":"232","author":"Nordstrom","year":"1992","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib11","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.116.4.909","article-title":"Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race","volume":"116","author":"Stein","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00001648-200107000-00016","article-title":"Increased risks of circulatory diseases in late pregnancy and puerperium","volume":"12","author":"Salonen","year":"2001","journal-title":"Epidemiology"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1067\/mob.2000.105405","article-title":"The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes","volume":"182","author":"Kovacevich","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib16","first-page":"155","article-title":"The risk of thrombo-embolism in pregnancy and in the post-partum period. A review of 28,828 pregnancies (author's transl)","volume":"10","author":"Rudigoz","year":"1981","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib18","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib20","doi-asserted-by":"crossref","unstructured":"Gates S, Brocklehurst P, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period (Cochrane review). Cochrane Database Syst Rev; 2002:CD001689.","DOI":"10.1002\/14651858.CD001689"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib21","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(02)08740-8","article-title":"Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women","volume":"359","author":"Clark","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(00)02382-5","article-title":"Oral contraceptives and fatal pulmonary embolism","volume":"355","author":"Parkin","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib24","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case\u2013control study","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib26","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib27","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case\u2013control analysis","volume":"321","author":"Jick","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib29","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0895-4356(95)00516-1","article-title":"A multinational case\u2013control study of cardiovascular disease and steroid hormone contraceptives. Description and validation of methods","volume":"48","author":"World Health Organization Collaborative Study of Cardiovascular Steroid Hormone Contraception","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0010-7824(99)00011-6","article-title":"The risk of venous thromboembolism in users of postcoital contraceptive pills","volume":"59","author":"Vasilakis","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0015-0282(99)00318-0","article-title":"Screening for factor V Leiden mutation before prescribing combination oral contraceptives","volume":"72","author":"Creinin","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(96)24041-3","article-title":"Case\u2013control study of venous thromboembolism risk in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/Progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: population based case\u2013control study","volume":"314","author":"Perez","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/oxfordjournals.aje.a009461","article-title":"Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe","volume":"147","author":"Varas-Lorenzo","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib38","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib41","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/bmj.311.7011.977","article-title":"Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group","volume":"311","author":"McDonald","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","article-title":"Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial","volume":"352","author":"Powles","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)04394-3","article-title":"Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study","volume":"352","author":"Veronesi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/bmj.326.7383.254","article-title":"Influence of the third generation pill controversy on prescriptions for oral contraceptives among first time users: population based study","volume":"326","author":"Jong-van den Berg","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib46","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM199504063321403","article-title":"Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men","volume":"332","author":"Ridker","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.2001.02981.x","article-title":"Investigation and management of heritable thrombophilia","volume":"114","author":"Haemostasis Thrombosis Task Force British Committee for Standards in Haematology","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bmj.326.7384.322","article-title":"Making decisions about hormone replacement therapy","volume":"326","author":"Rymer","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib50","unstructured":"Alonso Ortiz del R\u00edo C, Medrano Ortega FJ, Romero Alonso A, Villar Conde E, Calder\u00f3n Sandubete E, Mar\u00edn Le\u00f3n I y Cols. PRETEMED Guideline 2003. Prevention of thromboembolic venous disease in medical patients. 1st ed. C\u00f3rdoba (Spain): SADEMI; 2003. http:\/\/www.redeguias.net\/Documentos\/pretemed\/OKTrad.Pretemed.pdf."},{"key":"10.1016\/j.ejogrb.2004.11.023_bib51","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/096721099600400618","article-title":"Venous thrombotic complications of pregnancy","volume":"4","author":"James","year":"1996","journal-title":"Cardiovasc Surg"},{"key":"10.1016\/j.ejogrb.2004.11.023_bib53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504006128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211504006128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:12:58Z","timestamp":1759554778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211504006128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0301211504006128"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.11.023","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of venous thromboembolic disease in women","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2004.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}